APA (7th ed.) Citation

Tosetti, G., Degasperi, E., Farina, E., Primignani, M., & Lampertico, P. (2023). Carvedilol to reduce the risk of decompensation in patients with compensated cirrhosis: Is it really needed in patients with cured HCV or suppressed HBV? Journal of hepatology, 79(5), e200-e202. https://doi.org/10.1016/j.jhep.2023.03.026

Chicago Style (17th ed.) Citation

Tosetti, Giulia, Elisabetta Degasperi, Elisa Farina, Massimo Primignani, and Pietro Lampertico. "Carvedilol to Reduce the Risk of Decompensation in Patients with Compensated Cirrhosis: Is It Really Needed in Patients with Cured HCV or Suppressed HBV?" Journal of Hepatology 79, no. 5 (2023): e200-e202. https://doi.org/10.1016/j.jhep.2023.03.026.

MLA (9th ed.) Citation

Tosetti, Giulia, et al. "Carvedilol to Reduce the Risk of Decompensation in Patients with Compensated Cirrhosis: Is It Really Needed in Patients with Cured HCV or Suppressed HBV?" Journal of Hepatology, vol. 79, no. 5, 2023, pp. e200-e202, https://doi.org/10.1016/j.jhep.2023.03.026.